Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and the association with other autoimmune diseases is well-documented. There are many therapeutic options for the treatment of MS. Most of the available drugs cause drug-induced liver injury (DILI) to variable e...

Descripción completa

Detalles Bibliográficos
Autores principales: Meunier, Lucy, Larrey, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821303/
https://www.ncbi.nlm.nih.gov/pubmed/36614299
http://dx.doi.org/10.3390/ijms24010852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821303/
https://www.ncbi.nlm.nih.gov/pubmed/36614299
http://dx.doi.org/10.3390/ijms24010852

Ejemplares similares